Paper39211396
Treatment Pathways in Patients With Crohn's Disease and Ulcerative Colitis: Understanding the Road to Advanced Therapy.
Siegel CA and 5 others. Crohns Colitis 360, 2024. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Treatment Pathways in Patients With Crohn's Disease and Ulcerative Colitis: Understanding the Road to Advanced Therapy. Papers, record 39211396. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39211396
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Treatment Pathways in Patients With Crohn's Disease and Ulcerative Colitis: Understanding the Road to Advanced Therapy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34513436 | A Review of Four Practice Guidelines of Inflammatory Bowel Disease. | Cureus | 2021 | https://conductscience.org/library/papers/34513436 | PubMed |
| 2 | 29562277 | Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I. | Inflamm Bowel Dis | 2018 | https://conductscience.org/library/papers/29562277 | PubMed |
| 3 | 35956201 | Machine Learning Can Predict the Probability of Biologic Therapy in Patients with Inflammatory Bowel Disease. | J Clin Med | 2022 | https://conductscience.org/library/papers/35956201 | PubMed |
| 4 | 33159475 | Fatigue in inflammatory bowel disease and its impact on daily activities. | Aliment Pharmacol Ther | 2021 | https://conductscience.org/library/papers/33159475 | PubMed |
| 5 | 37506265 | Early Biologic Treatment Decreases Risk of Surgery in Crohn's Disease but not in Ulcerative Colitis: Systematic Review and Meta-Analysis. | Inflamm Bowel Dis | 2024 | https://conductscience.org/library/papers/37506265 | PubMed |
| 6 | 33885977 | Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. | J Gastroenterol | 2021 | https://conductscience.org/library/papers/33885977 | PubMed |
| 7 | 32100018 | Identifying IBD Providers' Knowledge Gaps Using a Prospective Web-based Survey. | Inflamm Bowel Dis | 2020 | https://conductscience.org/library/papers/32100018 | PubMed |
| 8 | 33663650 | Health Care Utilization Among U.S. Adults With Inflammatory Bowel Disease, 2015-2016. | Natl Health Stat Report | 2021 | https://conductscience.org/library/papers/33663650 | PubMed |
| 9 | 33569628 | Long-term cost and complications of surgery in patients with ulcerative colitis: a claims data analysis. | Int J Colorectal Dis | 2021 | https://conductscience.org/library/papers/33569628 | PubMed |
| 10 | 32026526 | Knowledge of disease and self-management of adolescents with inflammatory bowel diseases. | Acta Paediatr | 2020 | https://conductscience.org/library/papers/32026526 | PubMed |
| 11 | 31945371 | AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis. | Gastroenterology | 2020 | https://conductscience.org/library/papers/31945371 | PubMed |
| 12 | 38402895 | A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial. | Lancet Gastroenterol Hepatol | 2024 | https://conductscience.org/library/papers/38402895 | PubMed |
| 13 | 25989464 | Assessing fatigue in inflammatory bowel disease: comparison of three fatigue scales. | Aliment Pharmacol Ther | 2015 | https://conductscience.org/library/papers/25989464 | PubMed |
| 14 | 27269903 | Report: economic implications of inflammatory bowel disease and its management. | Am J Manag Care | 2016 | https://conductscience.org/library/papers/27269903 | PubMed |
| 15 | 33079065 | Developing Patient-Centered Inflammatory Bowel Disease-Related Educational Videos Optimized for Social Media: Qualitative Research Study. | JMIR Med Educ | 2020 | https://conductscience.org/library/papers/33079065 | PubMed |
| 16 | 34051983 | AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease. | Gastroenterology | 2021 | https://conductscience.org/library/papers/34051983 | PubMed |
| 17 | 36777424 | Indicators of Suboptimal Treatment and Associated Healthcare Costs Among Patients With Crohn's Disease Initiated on Biologic or Conventional Agents. | Crohns Colitis 360 | 2022 | https://conductscience.org/library/papers/36777424 | PubMed |
| 18 | 29688466 | Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part II. | Inflamm Bowel Dis | 2018 | https://conductscience.org/library/papers/29688466 | PubMed |
| 19 | 18295023 | Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. | Lancet | 2008 | https://conductscience.org/library/papers/18295023 | PubMed |
| 20 | 33359090 | STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. | Gastroenterology | 2021 | https://conductscience.org/library/papers/33359090 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943287 | Changing Prescription Patterns in Pharmacologically Treated Patients with Newly Diagnosed Inflammatory Bowel Disease in German Gastroenterology Practices: A Real-World Study, 2015-2024. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943287 | PubMed |
| 42523912 | The efficacy and safety of etrasimod as a first-line advanced therapy for ulcerative colitis: prespecified and post hoc subgroup data from the ELEVATE UC clinical program. | Ther Adv Gastroenterol | 2026 | https://conductscience.org/library/papers/42523912 | PubMed |
| 42231661 | Understanding Patient and Gastroenterologist Preferences at the Time of Treatment Escalation to First-Line Advanced Therapy in Ulcerative Colitis: A Discrete Choice Experiment in Five European Countries. | United European Gastroenterol J | 2026 | https://conductscience.org/library/papers/42231661 | PubMed |
| 41884650 | Redefining Early Intervention and the Window of Opportunity in Crohn's Disease. | Gastroenterol Hepatol (N Y) | 2026 | https://conductscience.org/library/papers/41884650 | PubMed |
| 41125135 | Anti-tumor necrosis factor treatment from diagnosis is more effective and less costly than conventional "step-up" care for patients with active Crohn's disease: a cost-effectiveness analysis from the PROFILE trial. | J Crohns Colitis | 2025 | https://conductscience.org/library/papers/41125135 | PubMed |
| 40848228 | Cost-Utility Analysis of Treatment Sequences for Moderate-to-Severe Crohn's Disease. | Pharmacoeconomics | 2025 | https://conductscience.org/library/papers/40848228 | PubMed |
| 40591228 | 20-Year Mortality in a Population-Based Cohort of Patients with Inflammatory Bowel Disease from New Zealand. | Dig Dis Sci | 2025 | https://conductscience.org/library/papers/40591228 | PubMed |
| 40339064 | Disparities in Access and Treatment for Rural Patients With Inflammatory Bowel Disease: A Survey of Inflammatory Bowel Disease Patients and Providers. | Inflamm Bowel Dis | 2025 | https://conductscience.org/library/papers/40339064 | PubMed |
| 40222016 | Safety Outcomes in Patients With Ulcerative Colitis Using a Healthcare Administrative Database in the United States. | Inflamm Bowel Dis | 2025 | https://conductscience.org/library/papers/40222016 | PubMed |
| 39740876 | Microbiome and Mucosal Immunity in the Intestinal Tract. | In Vivo | 2025 | https://conductscience.org/library/papers/39740876 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39211396
GET https://conductscience.org/api/papers/v1/39211396/references?page=2